Nacer E Abbas

Title: Nacer E Abbas: Innovator in Molecular Diagnosis

Introduction

Nacer E Abbas is a prominent inventor based in Houston, Texas. He has made significant contributions to the field of molecular diagnostics, particularly in relation to Charcot-Marie-Tooth disease. His innovative work has the potential to improve the detection and understanding of this hereditary condition.

Latest Patents

Nacer E Abbas holds a patent for the "Molecular diagnosis of autosomal dominant Charcot-Marie-Tooth disease." This patent describes an isolated CMTIA-REP sequence and DNA probes associated with the sequence. The methods outlined in the patent enable the detection of peripheral neuropathies. Specifically, it includes a method for detecting Charcot-Marie-Tooth disease type 1 by measuring the presence or absence of a DNA duplication in a gene locus linked to the CMTIA-REP sequence. Additionally, it provides a method for detecting Hereditary Neuropathy with Liability to Pressure Palsies by measuring the presence or absence of a DNA deletion in the same gene locus.

Career Highlights

Nacer E Abbas is affiliated with the Baylor College of Medicine, where he continues to advance his research and innovations. His work is crucial in the field of genetics and molecular diagnostics, contributing to better healthcare solutions for patients with genetic disorders.

Collaborations

Nacer has collaborated with notable colleagues, including James R Lupski and Liu Pentao. These partnerships enhance the research and development of diagnostic methods in the medical field.

Conclusion

Nacer E Abbas is a key figure in the advancement of molecular diagnostics for Charcot-Marie-Tooth disease. His innovative patent and ongoing research at Baylor College of Medicine highlight his commitment to improving patient outcomes through scientific discovery.